Kinesin Like Protein KIF11 Inhibitors Market By Inhibitor Type ( 4SC-205, ALN-VSP, BIND-267, BQS-481 ), By Application ( Colorectal Cancer, Breast Cancer, Kidney Cancer, Liver Cancer ), Industry Trends, Estimation & Forecast, 2017 - 2025

  • Published On: Apr, 2018
  • Category: Healthcare
  • Pages: 162
kinesin Like Protein KIF11 Inhibitors Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.

Market Overview:

Kinesin like protein KIF11 is a motor protein encoded by the KIF11 gene. It is an essential protein that is required for the mitotic division of cells, as it regulates the formation of spindle fibers during mitosis. Moreover, KIF11 protein is also required for the movement of secretory proteins from the Golgi complex towards the cell surface. The inhibition of kinesin like protein KIF11 during mitosis leads to the inhibition of cell division, which ultimately results in cell death. Thus, kinesin like protein KIF11 inhibitors are being developed to target the active KIF11 proteins during abnormal cell division, such as in the case of cancer. The surge in the number of cancer diagnosis across the world and the need to control the abnormal cell division in the body is fuelling the growth of global kinesin like protein KIF11 inhibitors market. According to the American Cancer Society, in 2018, approximately 1,735,350 new cases of cancer are expected to be diagnosed in the United States, as compared to the estimated 1,685,210 cancer cases in the year 2016. However, the recorded side effects of such inhibitors on the nervous system are expected to hamper the growth of kinesin like protein KIF11 inhibitors market. The market is expected to offer lucrative opportunities to the market players during the upcoming years, owing to the continuous research and investments in the development of potential KIF11 protein inhibitors. The report provides detailed qualitative and quantitative analysis of the global kinesin like protein KIF11 inhibitors market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type, and end-use in each of the major regions of the world.

Kinesin Like Protein KIF11 Inhibitors Market Segmentation

By Inhibitor Type • 4SC-205 • ALN-VSP • BIND-267 • BQS-481 • Others By Application • Colorectal Cancer • Breast Cancer • Kidney Cancer • Liver Cancer • Others By Geography • North America o U.S. o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET OVERVIEW 2.1. KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET INTRODUCTION 2.2. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Kinesin like Protein KIF11 Inhibitors Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Kinesin like Protein KIF11 Inhibitors Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Kinesin like Protein KIF11 Inhibitors Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Kinesin like Protein KIF11 Inhibitors Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET PRICE TREND, 2017-2025 2.6.1. Global Kinesin like Protein KIF11 Inhibitors Market Price Trend and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET BY INHIBITOR TYPE, 2017-2025 3.1. 4SC-205 3.2. ALN-VSP 3.3. BIND-267 3.4. BQS-481 3.5. OTHERS 3.6. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET REVENUE BY INHIBITOR TYPE, 2017-2025 3.6.1. Global Kinesin like Protein KIF11 Inhibitors Market Revenue (Million USD) and Share (%) By Inhibitor type, 2017-2025 3.6.2. 4SC-205 Market Revenue and Growth Rate, 2017-2025 3.6.3. ALN-VSP Market Revenue and Growth Rate, 2017-2025 3.6.4. BIND-267 Market Revenue and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other inhibitor type segment. 3.7. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET PRODUCTION BY INHIBITOR TYPE, 2017-2025 3.7.1. Global Kinesin like Protein KIF11 Inhibitors Market Production (Volume) and Share (%) By Inhibitor type, 2017-2025 3.7.2. 4SC-205 Market Production and Growth Rate, 2017-2025 3.7.3. ALN-VSP Market Production and Growth Rate, 2017-2025 3.7.4. BIND-267 Market Production and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other inhibitor type segment. CHAPTER 4. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET BY APPLICATION, 2017-2025 4.1. COLORECTAL CANCER 4.2. BREAST CANCER 4.3. KIDNEY CANCER 4.4. LIVER CANCER 4.5. OTHERS 4.6. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET REVENUE BY APPLICATION, 2017-2025 4.6.1. Global Kinesin like Protein KIF11 Inhibitors Market Revenue (Million USD) and Share (%) By Application, 2017-2025 4.6.2. Colorectal Cancer Market Revenue and Growth Rate, 2017-2025 4.6.3. Breast Cancer Market Revenue and Growth Rate, 2017-2025 4.6.4. Kidney Cancer Market Revenue and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other application segment. 4.7. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET CONSUMPTION BY APPLICATION, 2017-2025 4.7.1. Global Kinesin like Protein KIF11 Inhibitors Market Consumption (Volume) and share (%) By Application, 2017-2025 4.7.2. Colorectal Cancer Market Consumption and Growth Rate, 2017-2025 4.7.3. Breast Cancer Market Consumption and Growth Rate, 2017-2025 4.7.4. Kidney Cancer Market Consumption and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other application segment. CHAPTER 5. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Kinesin like Protein KIF11 Inhibitors Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Kinesin like Protein KIF11 Inhibitors Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Kinesin like Protein KIF11 Inhibitors Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Kinesin like Protein KIF11 Inhibitors Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Kinesin like Protein KIF11 Inhibitors Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Kinesin like Protein KIF11 Inhibitors Market Share (%) of Top 3 Manufacturers 8.3.2. Kinesin like Protein KIF11 Inhibitors Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL KINESIN LIKE PROTEIN KIF11 INHIBITORS MANUFACTURERS ANALYSIS 9.1. 4SC AG 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Kinesin like Protein KIF11 Inhibitors Product Details 9.1.4. 4SC AG Kinesin like Protein KIF11 Inhibitors Production, Revenue and Gross Margin 9.2. ALNYLAM PHARMACEUTICALS, INC. 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Kinesin like Protein KIF11 Inhibitors Product Details 9.2.4. Alnylam Pharmaceuticals, Inc. Kinesin like Protein KIF11 Inhibitors Production, Revenue and Gross Margin 9.3. ARRAY BIOPHARMA INC. 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Kinesin like Protein KIF11 Inhibitors Product Details 9.3.4. Array BioPharma Inc. Kinesin like Protein KIF11 Inhibitors Production, Revenue and Gross Margin 9.4. KYOWA HAKKO KIRIN 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Kinesin like Protein KIF11 Inhibitors Product Details 9.4.4. Kyowa Hakko Kirin Kinesin like Protein KIF11 Inhibitors Production, Revenue and Gross Margin 9.5. MERCK & CO., INC. 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Kinesin like Protein KIF11 Inhibitors Product Details 9.5.4. Merck & Co., Inc. Kinesin like Protein KIF11 Inhibitors Production, Revenue and Gross Margin 9.6. NOVARTIS AG 9.6.1. Business Overview 9.6.2. Company Basic Information 9.6.3. Kinesin like Protein KIF11 Inhibitors Product Details 9.6.4. Novartis AG Kinesin like Protein KIF11 Inhibitors Production, Revenue and Gross Margin 9.7. PFIZER INC. 9.7.1. Business Overview 9.7.2. Company Basic Information 9.7.3. Kinesin like Protein KIF11 Inhibitors Product Details 9.7.4. Pfizer Inc. Kinesin like Protein KIF11 Inhibitors Production, Revenue and Gross Margin CHAPTER 10. KINESIN LIKE PROTEIN KIF11 INHIBITORS MARKET VALUE CHAIN ANALYSIS 10.1. KINESIN LIKE PROTEIN KIF11 INHIBITORS INDUSTRIAL CHAIN ANALYSIS 10.2. KINESIN LIKE PROTEIN KIF11 INHIBITORS KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. MARKETING CHANNEL 10.3.1. Direct Marketing 10.3.2. Indirect Marketing 10.3.3. Distributors/Traders 10.4. CONSUMER ANALYSIS 10.4.1. Consumer 1 10.4.2. Consumer 2 10.4.3. Consumer 3 10.4.4. Consumer 4

• 4SC AG
• Alnylam Pharmaceuticals, Inc.
• Array BioPharma Inc.
• Kyowa Hakko Kirin
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS